-
2023-504999-25-00
5
2023-07-14
Acute Myeloid Leukemia
-
2022-500587-35-01
5
2023-07-06
Stroke
-
2023-504661-23-00
5
2023-06-27
Antiphospholipid antibodies
-
2024-515997-28-00
5
2023-06-16
Patients resuscitated from out-of-hospital cardiac arrest
-
2022-502051-56-00
5
2023-04-28
H3 K27M-mutant diffuse glioma
-
2022-501072-25-02
4
2023-04-12
Ischemic Stroke
-
2022-501006-34-01
5
2023-03-29
Liver cirrhosis
-
2023-507396-21-00
4
2023-03-16
transfusion-dependent α- or β-thalassemia or low-risk myelodysplastic
-
2022-500646-14-00
4
2023-01-31
cancer
-
2024-514139-50-00
5
2022-11-14
Multiple myeloma
-
2024-515998-94-00
5
2022-11-10
We investigate the efficacy of two pharmaceutical interventions for re
-
2023-504885-50-00
5
2022-11-07
Treatment of children with chronic kidney disease and proteinuria
-
2023-510346-25-00
5
2022-09-01
Hypereosinophilic Syndrome (HES)
-
2024-515346-17-00
6
2022-08-01
Non-obstructive hypertrophic cardiomyopathy
-
2022-500125-32-00
6
2022-06-20
Myocardial infarction
-
2024-516072-15-00
6
2022-06-16
Neonates (postmenstrual age below 47 weeks) undergoing general anesthe
-
2023-503174-20-00
4
2022-05-30
KRAS G12C-mutated non-small cell lung cancer
-
2024-511601-34-00
6
2022-03-19
Patients undergoing surgical aortic valve replacement.
-
2024-514590-22-00
7
2022-03-10
Subarachnoid haemorrhage – SAH
-
2023-508963-58-00
4
2022-01-31
Symptomatic hypertrophic cardiomyopathy (HCM)
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2022-501563-40-00
1
2021-12-16
Solid tumor cancer and lung cancer
-
2024-510578-25-00
5
2021-11-05
Histologically proven high-risk medulloblastoma, with any of the curre
-
2024-516728-32-00
10
2021-10-29
Indolent Systemic Mastocytosis and SSM